Showing results (1-10 of 87) with videos related to
Sort By:
Pageof 9
Wiener Medizinische Wochenschrift (1946)|December 25, 2007
["Targeted Therapies" in NSCLC - present and future]Georg Pall, Wolfgang HilbeAnticancer Research|August 27, 2011
Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancerAndreas Pircher, Ernst Ulsperger, Rene Hack, et al.Wiener Klinische Wochenschrift|December 25, 2007
[Small cell lung cancer]Stefan Hoschek, Ursula Hoschek-Risslegger, Michael Fiegl, et al.Wiener Medizinische Wochenschrift (1946)|December 25, 2007
[Updated strategies in Small Cell Lung Cancer post ASCO 2007]Stefan Hoschek, Ursula Hoschek-Risslegger, Michael Fiegl, et al.Current Opinion in Oncology|November 24, 2020
Neoadjuvant immunotherapy in nonsmall cell lung cancerGeorg PallBMC Cancer|August 25, 2017
Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world settingMonika Sztankay, Johannes Maria Giesinger, August Zabernigg, et al.Lung Cancer (Amsterdam, Netherlands)|May 2, 2021
Advances in the treatment of RET-fusion-positive lung cancerGeorg Pall, Oliver GautschiLung Cancer (Amsterdam, Netherlands)|May 1, 2014
Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patientsAndreas Pircher, Gabriele Gamerith, Arno Amann, et al.Translational Lung Cancer Research|March 26, 2015
Targeting angiogenesis in lung cancer - Pitfalls in drug developmentWolfgang Hilbe, Christian Manegold, Andreas PircherPageof 9